Skip to main content


  • Sunday, Aug 24th
    11:15 AM - 11:30 AM ET
    1D-04 - Current approaches to observational study designs and analytical options to evaluate the safety of multi-dose vaccines: A systematic review
    Presenting Author: Monica Mtei, MD, MSc – London School of Hygiene and Tropical Medicine
    Co-Author: Tu Pham Hien Trang – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
    Co-Author: Adoración Navarro-Torné – GlaxoSmithKline (GSK),
    Co-Author: Ian Douglas – London School of Hygiene and Tropical Medicine
    Co-Author: Anna Schultze – London School of Hygiene and Tropical Medicine
    Methods in Pharmacoepidemiology / Study Design
  • Sunday, Aug 24th
    1:30 PM - 3:00 PM ET
    SW-1F - Integrating Real-World Data with Randomized Controlled Trials: Advancing Evidence Generation
    Location: 201
    Co-Author: Jessica C. Young, PhD – Karolinska Institutet
    Presenting Author: Emilie Toresson Grip – Quantify Research
    Co-Author: Kirk Geale, MSc, PhD – Quantify Research
    Co-Author: Rachael K. Ross, PhD – Columbia University
    Co-Author: Jennifer Christian, PhD, PharmD, FISPE – Target RWE
    Co-Author: Mary E. Ritchey, PhD, FISPE – Med Tech Epi
    Methods in Pharmacoepidemiology / Study Design
  • Sunday, Aug 24th
    3:30 PM - 3:45 PM ET
    2C-01 - Is the Climb Worth the View? Estimating COVID-19 Vaccine Effectiveness (VE) using Nested Trials vs. Traditional Matched Cohort Design
    Co-Author: Tianyi Lu – Moderna Inc.
    Co-Author: Tianyu Sun – Moderna Inc.
    Co-Author: Amanda Wilson – Moderna Inc.
    Co-Author: Michelle Skornicki – Aetion Inc.
    Presenting Author: Neloufar Rahai, PhD, MPH – Aetion Inc.
    Co-Author: Nan Shao – Moderna Inc.
    Co-Author: Elisha Beebe – Aetion Inc.
    Co-Author: Rohan Shah – Aetion Inc.
    Co-Author: Brent Arakaki – Aetion
    Co-Author: Katherine Mues – Aetion Inc.
    Co-Author: Andre Araujo – Moderna Inc.
    Co-Author: Brian Conroy – Aetion Inc.
    Methods in Pharmacoepidemiology / Study Design
  • Sunday, Aug 24th
    3:40 PM - 3:45 PM ET
    2D-03 - Mind the gap: a simulation study to compare definitions of treatment discontinuation
    Presenting Author: Alexander Breskin – Regeneron Pharmaceuticals, Inc.
    Co-Author: Mengying Li, MSPH, PhD – Regeneron Pharmaceuticals, Inc.
    Co-Author: Olivier Humblet – Regeneron Pharmaceuticals, Inc. Tarrytown, NY, USA
    Co-Author: Chase D. Latour – Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Co-Author: Julius Asubonteng – Regeneron Pharmaceuticals, Inc.
    Co-Author: Christian Hampp – Regeneron Pharmaceuticals, Inc.
    Co-Author: Jessica J. Jalbert – Regeneron Pharmaceuticals
    Co-Author: Rachel E. Sobel – Regeneron Pharmaceuticals, Inc.
    Methods in Pharmacoepidemiology / Study Design
  • Sunday, Aug 24th
    4:30 PM - 4:45 PM ET
    2E-05 - Use of alternative study designs in evaluating comparative risks of infections among patients with moderate-to-severe psoriasis treated with newer vs. older immunomodulatory treatments
    Presenting Author: Yinzhu Jin – Brigham and Women's Hospital
    Co-Author: Maria Schneeweiss – Brigham and Women's Hospital
    Co-Author: Priyanka Anand – Brigham and Women's Hospital
    Co-Author: Susan S. Jick, DSc – Boston Collaborative Drug Surveillance Program
    Co-Author: Rishi Desai, MS, PhD – Harvard Medical School
    Co-Author: Sebastian Schneeweiss, MD, ScD – Brigham and Women's Hospital and Harvard Medical School
    Methods in Pharmacoepidemiology / Study Design
  • Sunday, Aug 24th
    4:45 PM - 5:00 PM ET
    2E-06 - Impacts of RWD-related biases in Bayesian borrowing through the use of simulation study
    Presenting Author: Angela Zhu, PhD – Boehringer Ingelheim Pharmaceuticals Inc,
    Co-Author: Victoria Strauss – Boehringer Ingelheim
    Co-Author: Matthew Valko, PhD – Boehringer Ingelheim Pharmaceuticals Inc,
    Co-Author: Dooti Roy, PhD – Boehringer Ingelheim Pharmaceuticals Inc
    Co-Author: Mitchell Thomann – Boehringer Ingelheim Pharmaceuticals Inc.
    Methods in Pharmacoepidemiology / Study Design
  • Sunday, Aug 24th
    5:15 PM - 6:45 PM ET
    SW-2B - The Clone-Censor-Weight Approach: From Basic Principles to Its Transformation in Diverse Exposure and Outcome Scenarios
    Location: Ballroom AB
    Presenting Author: Daniel Hsiang-Te Tsai – Population Health Data Center, National Cheng Kung University, Tainan, Taiwan
    Co-Author: Kenneth Man – School of Pharmacy, University College London
    Co-Author: Avery Shuei-He Yang, MClinPharm – School Of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University
    Co-Author: Charles E. Gaber, PhD, MPH – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago
    Co-Author: Jennifer L. Lund, PhD, MSPH – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
    Co-Author: Edward Chia-Cheng Lai, PhD – Population Health Data Center, National Cheng Kung University
    Methods in Pharmacoepidemiology / Study Design
  • Monday, Aug 25th
    9:15 AM - 9:30 AM ET
    3D-05 - Pitfalls of Using AI Tools to Write Statistical Analysis Plans for Pharmacoepidemiology Target Trial Emulation in Electronic Health Insurance Databases Without Pre-Training
    Presenting Author: Peter Pin-Sung Liu, PhD – Population Health Data Center, National Cheng Kung University
    Co-Author: Miyuki Hsing-Chun Hsieh, PhD – Population Health Data Center, National Cheng Kung University
    Co-Author: Edward Chia-Cheng Lai, PhD – Population Health Data Center, National Cheng Kung University
    Methods in Pharmacoepidemiology / Study Design
  • Monday, Aug 25th
    1:00 PM - 2:30 PM ET
    SW-3A - Navigating Around Quicksand: Mapping the Complexities of Externally Controlled Trial (ECT) Designs
    Location: 208AB
    Presenting Author: Michele Jonsson Funk, PhD – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
    Co-Author: Jennifer L. Lund, PhD, MSPH – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
    Co-Author: Donna Rivera – Food and Drug Administration
    Co-Author: Gerd Rippin, PhD – IQVIA
    Co-Author: Catherine C. Lerro, PhD, MPH – Oncology Center of Excellence
    Co-Author: Ann Marie McNeill, PhD, MPH – AbbVie
    Co-Author: Jennifer S. Fusco – Epividian, Inc.
    Methods in Pharmacoepidemiology / Study Design
  • Monday, Aug 25th
    1:00 PM - 2:30 PM ET
    SW-3C - How should we interpret self-controlled study designs in the era of causal inference?
    Location: Ballroom AB
    Presenting Author: Kenneth Man – School of Pharmacy, University College London
    Co-Author: Siu Chung Andrew Yuen – School of Pharmacy, University College London
    Co-Author: Cindy Zhou – Moderna, Inc.
    Co-Author: Sudha Raman – Duke University
    Co-Author: Edward Chia-Cheng Lai, PhD – Population Health Data Center, National Cheng Kung University
    Co-Author: Ju-Young Shin, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
    Co-Author: Anna Schultze – London School of Hygiene and Tropical Medicine
    Methods in Pharmacoepidemiology / Study Design
  • Tuesday, Aug 26th
    8:30 AM - 8:45 AM ET
    5B-01 - Comparing the Use of Sequential Versus Non-sequential Target Trial Emulation in Estimating the Effect of Sodium Phenylbutyrate and Taurusodiol on Mortality in Individuals with Amyotrophic Lateral Sclerosis
    Co-Author: Queeny Ip – Komodo Health
    Co-Author: Yuqin Wei – Komodo Health
    Co-Author: Ting-Ying Huang – Komodo Health
    Co-Author: Ahmed Noman – Komodo Health
    Presenting Author: Kenneth A. Taylor, DPT, PhD – Komodo Health
    Methods in Pharmacoepidemiology / Study Design
  • Tuesday, Aug 26th
    9:00 AM - 9:15 AM ET
    5B-03 - Comparing Clone-Censoring Weighting and Sequential Trial Emulation in Estimating the Effect of Statins on Major Adverse Cardiovascular Events in Patients with Diabetes Mellitus
    Presenting Author: Peter Pin-Sung Liu, PhD – Population Health Data Center, National Cheng Kung University
    Co-Author: Daniel Hsiang-Te Tsai – Population Health Data Center, National Cheng Kung University, Tainan, Taiwan
    Co-Author: Avery Shuei-He Yang, MClinPharm – School Of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University
    Co-Author: Edward Chia-Cheng Lai, PhD – Population Health Data Center, National Cheng Kung University
    Methods in Pharmacoepidemiology / Study Design
  • Tuesday, Aug 26th
    10:30 AM - 12:00 PM ET
    SW-4D - Why Treatment Strategies are a Sine Qua Non of the Causal Estimand
    Location: Ballroom AB
    Presenting Author: Xabier García de Albéniz – RTI Health Solutions
    Co-Author: Barbra Dickerman – Harvard T.H. Chan School of Public Health
    Co-Author: John W. Jackson, ScD – Johns Hopkins Bloomberg School of Public Health
    Co-Author: Sonja Swanson – University of Pittsburgh
    Co-Author: John Seeger – RTI Health Solutions
    Methods in Pharmacoepidemiology / Study Design
  • Tuesday, Aug 26th
    10:30 AM - 12:00 PM ET
    SW-4F - Approaches to Time-Zero and Time-Related Bias in External Control Arm Study Design: Methodological Considerations and Applications
    Location: 204ABC
    Presenting Author: Ju Hwan Kim, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
    Co-Author: Samy Suissa, PhD – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada; Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada; Department of Medicine, McGill University, Montreal, Canada
    Co-Author: Laurent Azoulay, PhD – Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada
    Co-Author: Kenneth Man – School of Pharmacy, University College London
    Co-Author: Ju-Young Shin, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
    Methods in Pharmacoepidemiology / Study Design
  • Tuesday, Aug 26th
    2:00 PM - 2:15 PM ET
    6E-03 - A Target Trial Emulation with an Extension to Subgroups: an Example for Relapsing-Remitting Multiple Sclerosis
    Presenting Author: Stefan Verweij – University of Groningen
    Co-Author: Maarten Bijlsma – Max Planck Insitute for Demographic Research
    Co-Author: Katrien Oude Rengerink – Medicines Evaluation Board
    Co-Author: Eelko Hak – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
    Co-Author: Peter Mol – University Medical Center Groningen, Groningen, the Netherlands
    Methods in Pharmacoepidemiology / Study Design
  • Tuesday, Aug 26th
    2:00 PM - 2:15 PM ET
    6G-03 - Comparison of baseline characteristics in patients with prostate cancer who received radical prostatectomy or external beam radiotherapy: target trial versus real-world data population
    Presenting Author: Eng Hooi (Cheryl) Tan – University of Oxford
    Co-Author: Danielle Newby – University of Oxford
    Co-Author: Wai Yi Man – University of Oxford
    Co-Author: Antonella Delmestri, PhD – University of Oxford
    Co-Author: Nora Tabea Sibert – Health Services Research Department, German Cancer Society, Berlin, Germany
    Co-Author: Rossella Nicoletti – Department of clinical and experimental medicine, University of Florence, Italy
    Co-Author: Peter-Paul Willemse – Department of Urology, Cancer Center, UMC Utrecht, The Netherlands
    Co-Author: Monique Roobol – Erasmus University Medical Centre, Cancer Institute, Department of Urology, Rotterdam, The Netherlands
    Co-Author: Daan Nieboer – Erasmus University Medical Centre, Cancer Institute, Department of Urology, Rotterdam, The Netherlands
    Co-Author: Daniel Prieto-Alhambra – Health Data Sciences, Centre for Statistics in Medicine, University of Oxford
    Co-Author: OPTIMA Consortium – OPTIMA consortium
    Methods in Pharmacoepidemiology / Study Design
  • Tuesday, Aug 26th
    2:15 PM - 2:30 PM ET
    6E-04 - Comparison of Disease Risk Score Methods to Study Treatment Effect Heterogeneity in Real World Data: A Simulation Study
    Presenting Author: Haedi Thelen, PharmD – University of Pennsylvania
    Co-Author: Wei Yang, PhD – University of Pennsylvania
    Co-Author: Jordana Cohen, MD – University of Pennsylvania
    Co-Author: Sean Hennessy, PharmD, PhD – Center for Real-World Effectiveness and Safety of Therapeutics (CREST), Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania
    Co-Author: Wensheng Guo, PhD – University of Pennsylvania
    Co-Author: Todd Miano, PharmD, PhD – University of Pennsylvania
    Methods in Pharmacoepidemiology / Study Design
  • Tuesday, Aug 26th
    2:30 PM - 2:45 PM ET
    6F-05 - Comparison of Performance of Common Exposure Episode Definitions in Long-Latency Outcome Studies
    Presenting Author: Andrea Austin – CorEvitas, LLC
    Co-Author: Nicole Foster – CorEvitas, LLC
    Co-Author: Melissa Moore-Clingenpeel – CorEvitas
    Co-Author: Leslie Harrold, MD, MPH – CorEvitas, LLC
    Co-Author: Heather Litman – CorEvitas, LLC
    Methods in Pharmacoepidemiology / Study Design